Archive: 15. 4. 1989, Volume: 2, Issue: 2

flag
Klinicka onkologie Journal cover

General

Can we change the unfavourable prognosis in patients with hereditary colon adenomatosis?

Klin Onkol 1989; 2(2): 34-37.
Authors: Zoubek V.

Philadephia chromosome after 30 years

Klin Onkol 1989; 2(2): 38-42.
Authors: Vořechovský I.

The survival of women with breast cancer in the Trutnov area.

Klin Onkol 1989; 2(2): 43-48.
Authors: Hynek J., Zaydlar K., Müller K., Martinov Petr

Coexpression of CEA and CA 19-9 in patients with colorectal carcinoma

Klin Onkol 1989; 2(2): 49-52.
Authors: Žaloudík Jan, Fischer Jan, Fischerová E., Rejthar Aleš, Moore M.

The significance bulky irradiation in the palliative treatment of cancer

Klin Onkol 1989; 2(2): 53-55.
Authors: Kypěnová D., Konečný Milan

Primary chemotherapy with Mitoxantron and Prednisone in patients with advanced breast carcinoma.

Klin Onkol 1989; 2(2): 56.
Authors: Carmo-Pereira J.

Treatment of multiple myeloma with recombinant alfa-interferon

Klin Onkol 1989; 2(2): 57.
Authors: Quesada Jr. , Alexanian Raymond, Hawkins M., Barlogie Bart, Borden E., Itri I., Gutterman Ju.

Immune trombocytopenia followiing alfa interferon therapy in patients with cancer

Klin Onkol 1989; 2(2): 57.
Authors: J.D. J.D., Mc Laughlin P., Talpaz M., Quesada Jr.

The biology of interferon actions

Klin Onkol 1989; 2(2): 58.
Authors: Gastl Günther, Huber Ch.

Information

The trilateral oncological symposium Smolenice

Klin Onkol 1989; 2(2): 59-60.
Authors: Tóth Š.

Urogenital tract tumours - The european school of oncology

Klin Onkol 1989; 2(2): 60-62.
Authors: Šopková B.

V. World Conference of lung cancer - Interlaken

Klin Onkol 1989; 2(2): 63-64.
Authors: Baumohl J.